ATE216249T1 - Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung - Google Patents

Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung

Info

Publication number
ATE216249T1
ATE216249T1 AT93916420T AT93916420T ATE216249T1 AT E216249 T1 ATE216249 T1 AT E216249T1 AT 93916420 T AT93916420 T AT 93916420T AT 93916420 T AT93916420 T AT 93916420T AT E216249 T1 ATE216249 T1 AT E216249T1
Authority
AT
Austria
Prior art keywords
eggs
warm
directed
blooded animals
bacterial antigens
Prior art date
Application number
AT93916420T
Other languages
English (en)
Inventor
Ralph J Stolle
Lee R Beck
Original Assignee
Dcv Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22073631&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE216249(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dcv Inc filed Critical Dcv Inc
Application granted granted Critical
Publication of ATE216249T1 publication Critical patent/ATE216249T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Animal Husbandry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93916420T 1993-05-26 1993-05-28 Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung ATE216249T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6708893A 1993-05-26 1993-05-26
PCT/US1993/005198 WO1994027623A1 (en) 1993-05-26 1993-05-28 Anti-cholesterolemic egg, vaccine and method for production, and use

Publications (1)

Publication Number Publication Date
ATE216249T1 true ATE216249T1 (de) 2002-05-15

Family

ID=22073631

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93916420T ATE216249T1 (de) 1993-05-26 1993-05-28 Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung

Country Status (14)

Country Link
EP (1) EP0707485B1 (de)
JP (1) JPH09500870A (de)
AT (1) ATE216249T1 (de)
AU (1) AU690521B2 (de)
BR (1) BR9307851A (de)
CA (1) CA2163737A1 (de)
DE (1) DE69331836T2 (de)
DK (1) DK0707485T3 (de)
ES (1) ES2177546T3 (de)
FI (1) FI955692A (de)
IL (1) IL105845A0 (de)
NO (1) NO954717L (de)
NZ (1) NZ254326A (de)
WO (1) WO1994027623A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
JPS57144215A (en) * 1981-03-02 1982-09-06 Nippon Nousan Kogyo Kk Composition for improving lipometabolism
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US5215746A (en) * 1982-06-03 1993-06-01 Stolle Research And Development Corporation Anti-cholesterolemic egg, vaccine and method for production, and use
JPH0651632B2 (ja) * 1985-09-05 1994-07-06 昭和産業株式会社 降コレステロ−ル剤

Also Published As

Publication number Publication date
EP0707485A1 (de) 1996-04-24
JPH09500870A (ja) 1997-01-28
NO954717L (no) 1996-01-26
DE69331836D1 (de) 2002-05-23
NZ254326A (en) 1998-01-26
FI955692A (fi) 1996-01-24
DK0707485T3 (da) 2002-08-26
FI955692A0 (fi) 1995-11-24
IL105845A0 (en) 1993-12-28
EP0707485B1 (de) 2002-04-17
AU690521B2 (en) 1998-04-30
DE69331836T2 (de) 2002-08-22
BR9307851A (pt) 1996-03-19
CA2163737A1 (en) 1994-12-08
AU4597993A (en) 1994-12-20
WO1994027623A1 (en) 1994-12-08
NO954717D0 (no) 1995-11-22
ES2177546T3 (es) 2002-12-16

Similar Documents

Publication Publication Date Title
CZ20011720A3 (cs) Farmaceutický prostředek pro léčení imunitních onemocnění
IT8349510A0 (it) Procedimento per la produzione di acido ialuronico da colture batteriche
NO931372D0 (no) Behandling av autoimmunsykdommer ved oral administrering av autoantigener
ATE266417T1 (de) Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
ATE100325T1 (de) Verwendung von milch zur herstellung einer hyperimmunmilchverbindung zur behandlung von erkrankungen des atmungssystems bei saeugetieren.
ATE522229T1 (de) Anti-ngf-antikörper zur behandlung verschiedener erkrankungen
EP0394946A3 (de) Menschlicher monoklonaler Antikörper, seine Herstellung und seine Verwendung
DE69524389D1 (de) 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung
US5753268A (en) Anti-cholesterolemic egg, vaccine and method for production, and use
ATE166230T1 (de) Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
HUT35521A (en) Process for preparing a pharmaceutical composition containing a purified, detixicated endotoxine and a pyridine soluble extract of a microorganism
ATE174959T1 (de) Verfahren zur isolierung und kultivierung von transformierten zellen sowie verwendung dieser zellen zur herstellung individuumsspezifischer antikörper
DE3483252D1 (de) Verfahren zur induktion von antitumorimmunozyten, verfahren zur herstellung von antitumorimmunozyten und durch das verfahren hergestellte antitumorimmunozyten.
NZ310195A (en) Inhibin compositions and methods of enhancing production performance
DE3587681D1 (de) Vakzine und Serum für Endotoxin assoziierte Krankheit und Verfahren zur Herstellung derselben sowie Verfahren zur Immunisierung und Behandlung solcher Krankheiten, enttoxifierte Endotoxine und bakterielle Mutante.
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
NL7807152A (nl) Farmaceutisch preparaat met werking tegen bronchospas- men en tegen hoest, werkwijze voor de behandeling van bronchospasmen, bronchiale astma, obstructieve chroni- sche bronchitus en spasmodisch hoesten.
DK0548123T3 (da) Anti-inflammatorisk faktor, fremgangsmåde til isolering og anvendelse
ATE43500T1 (de) Herstellung von antikoerpern.
DE69331836D1 (de) Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung
AU3103493A (en) A process for the production of potatoes cooked in water or steam and deep-frozen
ATE198123T1 (de) Verfahren zur rekonstitution von rohem fleisch zur herstellung von rekonstituiertem rohfleisch durch zugabe von transglutaminase
ATE359814T1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
US5849349A (en) Anti-cholesterolemic egg, vaccine and method for production, and use
DK0394136T3 (da) Bakteriestammer af slægten Bifidobacterium med IgA induktionspotentiale

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties